Clinical trials
Phase 4 COVID-19 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brazilian Clinical Research Institute | 2 |
| Hospital Alemão Oswaldo Cruz | 2 |
| The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2 |
| Albert B. Sabin Vaccine Institute | 1 |
| Butantan Institute | 1 |
| D'Or Institute for Research and Education | 1 |
| Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 1 |
| Matthew Neal MD | 1 |
| University of Campinas, Brazil | 1 |
| University of Sao Paulo General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 14 |
| Acquired Immunodeficiency Syndrome | 1 |
| Arthritis, Rheumatoid | 1 |
| Coronavirus Infections | 1 |
| HIV Infections | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Pathologic Complete Response | 1 |
| Rheumatic Diseases | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.